Comparative capabilities of the speckle-tracking echocardiography technologiesin two-dimensional and three-dimensional modes in the detection of subclinical cardiotoxicity in patients with breast cancer

封面

如何引用文章

全文:

详细

Aim. The study was to assess the deformation properties of the left ventricle (LV) myocardium in patients with breast cancer initially and after anthracycline chemotherapy according to 2D and 3D speckle-tracking echocardiography (STE).

Material and methods. the study included 99 patients with triple negative breast cancer with hypertensionandnormotension. All patients underwent standard transthoracic echocardiography with assessment of systolic function of the LV. To assess the indicator of global longitudinal strain (GLS), as a marker of cardiotoxicity, STE was used in two-and three-dimensional modes. In the three-dimensional STE mode, a new strain parameter, the global area strain (GAS) was evaluated.

Results. The study showed that in patients with breast cancer for a more accurate assessment of LV systolic function (ejection fraction) it is advisable to use 3D-echocardiography. A comparative analysis revealed statistically significantly lower values of the GLS according to the three-dimensional mode of STE compared to two-dimensional. The study also evaluated a new strain parameter – GAS (%). In patients with breast cancer during ROC analysis with a value of ³≥-14.0, the GAS indicator for the development of subclinical cardiotoxicity showed a sensitivity of 81.5% and a specificity of 73.3%.

Сonclusion. the advantage of the STE in the three-dimensional mode, in contrast to the two-dimensional mode, is the simultaneous and more accurate assessment of LVEF. The value of the additional parameter of LV deformation – the area of deformation requires further study.

作者简介

M. Saidova

National Medical Research Center of Cardiology

Email: ani_avalian@mail.ru
ORCID iD: 0000-0002-3233-1862

д.м.н., проф., рук. отд.

俄罗斯联邦, Moscow

A. Avalyan

National Medical Research Center of Cardiology

编辑信件的主要联系方式.
Email: ani_avalian@mail.ru
ORCID iD: 0000-0003-0442-4495

мл. науч. сотр.

俄罗斯联邦, Moscow

E. Oshchepkova

National Medical Research Center of Cardiology

Email: ani_avalian@mail.ru
ORCID iD: 0000-0002-3253-0669

д.м.н., проф., гл. науч. сотр.

俄罗斯联邦, Moscow

V. Shitov

National Medical Research Center of Cardiology

Email: ani_avalian@mail.ru
ORCID iD: 0000-0002-8878-7340

мл. науч. сотр. отд.

俄罗斯联邦, Moscow

I. Chazova

National Medical Research Center of Cardiology

Email: ani_avalian@mail.ru
ORCID iD: 0000-0002-9822-4357

акад. РАН, д.м.н., проф., зам. ген. дир.

俄罗斯联邦, Moscow

参考

  1. Curigliano G, Cardinale D, Dent S, et al. Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management. CA Cancer J Clin. 2016;66:309-25. doi: 10.3322/caac.21341
  2. Curigliano G, еt al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol. 2020;31:171-90. doi: 10.1016/j.annonc.2019.10.023
  3. Pizzino F, Vizzari G, Bomzeret C, et al. Diagnosis of Chemotherapy Induced Cardiotoxicity. J Patient Cent Res Rev. 2014:121-7. doi: 10.17294/2330-0698.1025
  4. Bovelli D, Plataniotis G, Roila F. Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines. Ann Oncol. 2010;21:277-82. doi: 10.1093/annonc/mdq200
  5. Mondillo S, Galderisi M, Mele D, et al. Speckle-Tracking Echocardiography: A New Technique for Assessing Myocardial Function. J Ultrasound Med. 2011;30:71-8. doi: 10.7863/jum.2011.30.1.71
  6. Plana JC, et al. Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014;27:911-39. doi: 10.1016/j.echo.2014.07.012
  7. Авалян А.А., Саидова М. А., Ощепкова Е. В. и др. Современные подходы к выявлению ранней субклинической кардиотоксичности, индуцированной химиотерапией, у больных раком молочной железы. Евразийский кардиологический журнал. 2018;3:50-5 [Avalyan AA, Saidova MA, Oshchepkova E V, et al. Modern approaches to detecting early subclinical cardiotoxicity induced by chemotherapy in patients with breast cancer. Eur Heart J. 2018;3:50-5 (In Russ.)].
  8. Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al. 2016 ESC Position Paper on cancer treatment and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J. 2016. doi: 10.1093/eurheartj/ehw211
  9. Чазова И.Е., Тюляндин С.А., Виценя М.В. и др. Руководство по диагностике, профилактике и лечению сердечно-сосудистых осложнений противоопухолевой терапии. Ч. I. Системные гипертензии. 2017;14(3):6-20 [Chazova IY, Tyulyandin SA, Vitsenia MV, et al. Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Part I. Systemic Hypertension. 2017;14(3):6-20 (In Russ.)]. doi: 10.26442/2075-082X_14.3.6-20
  10. Kleijn SA, Mohamed FA Aly, Terwee CB, et al. O. Three-dimensional speckle tracking echocardiography for automatic assessment of global and regional left ventricular function based on area strain. J Am Soc Echocardiogr. 2011;24:314-21. doi: 10.1016/j.echo.2011.01.014
  11. Seo Y, Ishizu T, Atsumi A, et al. Three-Dimensional Speckle Tracking Echocardiography. Circ J. 2014:1290-301. doi: 10.1253/circj.CJ-14-0360
  12. Santoro C, et al. 2D and 3D strain for detection of subclinicalanthracyclinecardiotoxicity in breast cancerpatients: a balance with feasibility. Eur Heart J Cardiovasc Imaging. 2017:1-7. doi: 10.1093/ehjci/jex033
  13. Dorosz JL, Lezotte DC, Weitzenkamp DA, et al. Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis. J Am Coll Cardiol. 2012;59(20):1799-808. doi: 10.1016/j.jacc.2012.01.037
  14. Саидова М.А. Трехмерная эхокардиография: вчера, сегодня, завтра. Consilium Medicum. 2006;8(5):127-32 [Saidova MA. Three-dimensional echocardiography: yesterday, today, tomorrow. Consilium Medicum. 2006;8(5):127-32 (In Russ.)].
  15. Sorrentino R, Esposito R, Pezzullo E, et al. Real-time three-dimensional speckle tracking echocardiography: technical aspects and clinical applications. Research Reports in Clinical Cardiology. 2016;2016(7):147-58. doi: 10.2147/RRCC.S107374
  16. Radwan H, Hussein E. Value of global longitudinal strain by two dimensional speckle tracking echocardiography in predicting coronary artery disease severity. Egypt Heart J. 2017;69:95-101. doi: 10.1016/j.ehj.2016.08.001
  17. Ky B, Putt M, Sawaya H, et al. Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab. J Am Coll Cardiol. 2014; 63(8):809-16. doi: 10.1016/j.jacc.2013.10.061
  18. Sawaya H, Sebag IA, Plana JC, et al. Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients. Am J Cardiol. 2011;107(9):1375-80. doi: 10.1016/j.amjcard.2011.01.006
  19. Song F-Y, Shi J, Guo Y, et al. Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy. Int J Cardiovasc Imaging. 2017;33(6):857-68. doi: 10.1007/s10554-017-1082-6
  20. Boyd A, Stoodley P, Richards D, et al. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study. PLoS One. 2017;12(4):1-15. doi: 10.1371/journal.pone.0175544
  21. Chen J, et al. Early Detection of Cardiotoxicity by 3D Speckle Tracking Imaging of Area Strain in Breast Cancer Patients Receiving Chemotherapy. Еchocardiography. 2019;36(9):1682-8. doi: 10.1111/echo.14467
  22. Reant P, Barbot L, Touche C, et al. Evaluation of global left ventricular systolic function using three-dimensional echocardiography speckle-tracking strain parameters. J Am Soc Echocardiogr. 2012;25(1):68-79. doi: 10.1016/j.echo.2011.10.009

补充文件

附件文件
动作
1. JATS XML
下载
2. Figure: 1. Diagnostic significance of LVEF according to 2D-echocardiography as a marker of cardiotoxicity in breast cancer patients.

下载 (132KB)
索引源数据
3. Figure: 2. Diagnostic significance of LVEF according to 3D-echocardiography as a marker of cardiotoxicity in breast cancer patients

下载 (122KB)
索引源数据
4. Figure: 3. GLS indices in BC patients with AH and normotension before and after chemotherapy. Here and below in table. 3: * p <0.05.

下载 (82KB)
索引源数据
5. Figure: 4. Application of the STE method in a two-dimensional mode in a BC patient with AH before and after CT. Bull's eye presentation.

下载 (130KB)
索引源数据
6. Figure: 5. Diagnostic significance of GLS index as a marker of cardiotoxicity in breast cancer patients.

下载 (128KB)
索引源数据
7. Figure: 6. Comparison of STE in terms of GLS in BC patients with AH at baseline and after CT.

下载 (57KB)
索引源数据
8. Figure: 7. Comparison of STE in terms of GLS in breast cancer patients with normotension at baseline and after chemotherapy.

下载 (60KB)
索引源数据
9. Figure: 8. Diagnostic significance of GAS as a marker of cardiotoxicity in breast cancer patients with sensitivity 81.5%, specificity 73.3%.

下载 (129KB)
索引源数据

版权所有 © Consilium Medicum, 2020

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 
 


##common.cookie##